A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

Memory loss can point in more than one direction. A patient may seem to fit Alzheimer’s disease, only to have signs that also ...

The Food and Drug Administration on Monday approved Guardant Health' s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating ...

Before the symptoms of cognitive loss are severe enough to be diagnosed, something in the blood seems to be changing. That is ...

To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

The U.S. Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older.The maker of the test, Palo Alto, California-based ...

An FDA panel on Thursday endorsed a blood-based test for colorectal cancer (CRC) screening in adults 45 years and older at average risk for the disease, putting aside concerns over the test's low ...

Credit: Guardant. The Shield blood test for colorectal cancer screening is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood ...